DopaFuse Delivery System

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003372-41-ES (EUCTR)	27/07/2021	09/06/2021	Investigating the DopaFuse® Delivery Systemin Parkinson’s Disease Patients. Assessing safety, effect ...	Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa via th ...	Motor symptoms in Parkinson’s Disease. MedDRA version: 20.0;Level: PT;Classification code 10061536;T ...	Product Name: DopaFuse Delivery System INN or Proposed INN: levodopa Other descriptive name: LEVODOPA I ...	SynAgile Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 1;Phase 2	Spain;Luxembourg;Italy
2	EUCTR2020-003372-41-IT (EUCTR)	27/01/2021	15/06/2021	Investigating the DopaFuse® Delivery Systemin Parkinson's Disease Patients. Assessing safety, effect ...	Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa via th ...	Motor symptoms in Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Te ...	Product Name: DopaFuse Delivery System Product Code: [N04BA] INN or Proposed INN: LEVODOPA Other descri ...	SynAgile Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 2	Spain;Luxembourg;Italy

First Previous1Next Last